Show simple item record

dc.contributor.authorMorel, Mathieu
dc.contributor.authorShtrahman, Roman
dc.contributor.authorRotter, Varda
dc.contributor.authorNissim, Lior
dc.contributor.authorBar-Ziv, Roy H.
dc.date.accessioned2018-05-01T17:12:17Z
dc.date.available2018-05-01T17:12:17Z
dc.date.issued2016-07
dc.date.submitted2016-03
dc.identifier.issn0027-8424
dc.identifier.issn1091-6490
dc.identifier.urihttp://hdl.handle.net/1721.1/115130
dc.description.abstractSynthetic gene circuits are emerging as a versatile means to target cancer with enhanced specificity by combinatorial integration of multiple expression markers. Such circuits must also be tuned to be highly sensitive because escape of even a few cells might be detrimental. However, the error rates of decision-making circuits in light of cellular variability in gene expression have so far remained unexplored. Here, we measure the single-cell response function of a tunable logic AND gate acting on two promoters in heterogeneous cell populations. Our analysis reveals an inherent tradeoff between specificity and sensitivity that is controlled by the AND gate amplification gain and activation threshold. We implement a tumor-mimicking cellculture model of cancer cells emerging in a background of normal ones, and show that molecular parameters of the synthetic circuits control specificity and sensitivity in a killing assay. This suggests that, beyond the inherent tradeoff, synthetic circuits operating in a heterogeneous environment could be optimized to efficiently target malignant state with minimal loss of specificity. Keywords: synthetic gene circuits; cellular heterogeneity; cancer gene therapy; cell-state targeting; mammalian synthetic biologyen_US
dc.publisherNational Academy of Sciences (U.S.)en_US
dc.relation.isversionofhttp://dx.doi.org/10.1073/pnas.1604391113en_US
dc.rightsArticle is made available in accordance with the publisher's policy and may be subject to US copyright law. Please refer to the publisher's site for terms of use.en_US
dc.sourceNational Academy of Sciencesen_US
dc.titleCellular heterogeneity mediates inherent sensitivity–specificity tradeoff in cancer targeting by synthetic circuitsen_US
dc.typeArticleen_US
dc.identifier.citationMorel, Mathieu et al. “Cellular Heterogeneity Mediates Inherent Sensitivity–specificity Tradeoff in Cancer Targeting by Synthetic Circuits.” Proceedings of the National Academy of Sciences 113, 29 (July 2016): 8133–8138 © 2016 National Academy of Sciencesen_US
dc.contributor.departmentMassachusetts Institute of Technology. Research Laboratory of Electronicsen_US
dc.contributor.departmentMassachusetts Institute of Technology. Synthetic Biology Centeren_US
dc.contributor.mitauthorNissim, Lior
dc.relation.journalProceedings of the National Academy of Sciencesen_US
dc.eprint.versionFinal published versionen_US
dc.type.urihttp://purl.org/eprint/type/JournalArticleen_US
eprint.statushttp://purl.org/eprint/status/PeerRevieweden_US
dc.date.updated2018-04-13T18:37:16Z
dspace.orderedauthorsMorel, Mathieu; Shtrahman, Roman; Rotter, Varda; Nissim, Lior; Bar-Ziv, Roy H.en_US
dspace.embargo.termsNen_US
dc.identifier.orcidhttps://orcid.org/0000-0001-6495-4741
mit.licensePUBLISHER_POLICYen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record